Literature DB >> 25032806

Oncological applications of dual-energy computed tomography imaging.

Jijo Paul1, Thomas J Vogl, Emmanuel C Mbalisike.   

Abstract

Dual-energy computed tomography (DECT) imaging is a promising method used in oncology for accurate detection/diagnosis of malignant and benign lesions. Use of dual-energy spectral, weighted average, color-coded map, and virtual unenhanced images provides increased visual detection and easy lesion delineation. Lesion detectability, sensitivity, and conspicuity are significantly improved using DECT. Material characterization and decomposition are promising using DECT. Both anatomical and functional information related to oncology can be provided by DECT using single contrast-enhanced CT.

Entities:  

Mesh:

Year:  2014        PMID: 25032806     DOI: 10.1097/RCT.0000000000000133

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  New method for the assessment of perineural invasion from perihilar cholangiocarcinoma.

Authors:  Hiroshi Tanaka; Tsuyoshi Igami; Yoshie Shimoyama; Tomoki Ebata; Yukihiro Yokoyama; Kensaku Mori; Masato Nagino
Journal:  Surg Today       Date:  2020-07-04       Impact factor: 2.549

2.  Assessment of an Advanced Monoenergetic Reconstruction Technique in Dual-Energy Computed Tomography of Head and Neck Cancer.

Authors:  Moritz H Albrecht; Jan-Erik Scholtz; Johannes Kraft; Ralf W Bauer; Moritz Kaup; Patricia Dewes; Andreas M Bucher; Iris Burck; Jens Wagenblast; Thomas Lehnert; J Matthias Kerl; Thomas J Vogl; Julian L Wichmann
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

3.  Comparing dual energy CT and subtraction CT on a phantom: which one provides the best contrast in iodine maps for sub-centimetre details?

Authors:  Evelinda Baerends; Luuk J Oostveen; Casper T Smit; Marco Das; Ioannis Sechopoulos; Monique Brink; Frank de Lange; Mathias Prokop
Journal:  Eur Radiol       Date:  2018-05-28       Impact factor: 5.315

Review 4.  In vivo small animal micro-CT using nanoparticle contrast agents.

Authors:  Jeffrey R Ashton; Jennifer L West; Cristian T Badea
Journal:  Front Pharmacol       Date:  2015-11-04       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.